Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.
Am Heart J
; 158(4): 569-75, 2009 Oct.
Article
in En
| MEDLINE
| ID: mdl-19781416
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulin Fab Fragments
/
Platelet Aggregation Inhibitors
/
Angioplasty, Balloon, Coronary
/
Registries
/
Patient Transfer
/
Electrocardiography
/
Antibodies, Monoclonal
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Am Heart J
Year:
2009
Document type:
Article
Affiliation country:
Poland